Vimarsana
Biggest News Aggregation in the World

Page 2 - Vp Research Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vp Research Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vp Research Development Today - Breaking & Trending Today

Mustang Survival President Announces Resignation - Vimarsana News

Mustang Survival President Announces Resignation

Jason Leggatt, president of Mustang Survival and Andrew Branagh, the CEO of The Wing Group, announced that Leggatt had resigned from his position. He will remain with the company as a member of its Board.

Blaize Delivers First Open and Code-free AI Software Platform Spanning the Entire Edge AI Application Lifecycle - Vimarsana News

Blaize Delivers First Open and Code-free AI Software Platform Spanning the Entire Edge AI Application Lifecycle

Industry Articles Transforms productivity for faster ROI of AI edge deployments El DORADO HILLS, CA — December 14, 2020 — Blaize today fully unveiled the Blaize AI Studio offering, the industry’s first open and code-free software platform to span the complete edge AI operational workflow from idea to development, deployment and management. AI Studio dramatically reduces edge AI application deployment complexity, time, and cost by breaking the barriers within existing application development and machine learning operations (MLOps) infrastructure that hinder edge AI deployments. Eliminati...

Immunovia to Host a Third Webinar in the Series on IMMray PanCan-d: Verification Study and Clinical Use - Vimarsana News

Immunovia to Host a Third Webinar in the Series on IMMray PanCan-d: Verification Study and Clinical Use

(1) LUND, Sweden, Dec. 11, 2020 /PRNewswire/ -- Immunovia AB (publ) ("Immunovia"), a near-commercial stage diagnostics company developing ground-breaking antibody-based multiplex microarray technology platform called IMMray for the early detection of cancer, today announced that the company will be hosting the third webinar in the series on IMMray PanCan-d, Immunovia's test for early detection of pancreatic cancer. This third webinar will cover IMMray PanCan-d verification study results and its clinical use including feedback from experts in pancreatic cancer and pancreatic diseases. Event De...